Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.
Hyperalgesia and allodynia, lasting for months or even years, occurs in the form of post-herpetic neuralgia in approximately 70% of adults previously infected with the varicella herpes zoster virus. The present study aimed at testing the analgesic desensitising actions and reversibility of repeated application of topical capsaicin on disordered polymodal nociceptors and peptidergic sensory fibres mediating warm and pain sensation. Cutaneous nociceptor desensitisation was measured using the Glasgow automated thermal threshold test (Medelec TTT). For normal subjects (n = 69) the mean forearm warm threshold was 0.15 +/- 0.07 degrees C and the cold threshold was 0.14 +/- 0.10 degrees C. A variable degree of partial desensitisation of herpes-affected skin was found in 15 patients with post-herpetic neuralgia before capsaicin treatment where the mean threshold elevation for warm detection was 1.19 degrees C and 0.7 degrees C for cold detection, compared with the corresponding normal skin. In preliminary studies of 15 patients with post-herpetic neuralgia, good pain relief averaging 30% or 77% occurred in the affected dermatome(s) after 3 to 4 weeks of 0.01% or 0.05% capsaicin cream respectively, applied 3-4 times daily. The warm thresholds, after chronic capsaicin treatment, increased between 0.1 and 7.60 degrees C, the average elevation being 3.69 degrees C. By contrast cold thresholds after capsaicin altered inconsistently and by only an average of 0.08 degrees C. The results suggest that elevation of the warm threshold may indicate the desensitisation achieved by capsaicin treatment of skin polymodal nociceptors. Cold detection, being dependent upon A-delta cold fibre function, is unaffected by capsaicin treatment. There was a poor correlation between pain relief and elevation of warm detection in response to capsaicin treatment. Generally, it was found that those patients with less initial desensitisation to warm detection as a consequence of post-herpetic neuralgia experienced better pain relief after capsaicin was applied. The method used permits determination of the minimum effective desensitising dose of capsaicin, enables patient compliance and progress to be monitored and should allow the prediction of patients likely to achieve the best response to treatment.
Westerman
R A
RA
Department of Physiology, Monash University, Clayton, Vic.
Roberts
R G
RG
Kotzmann
R R
RR
Westerman
D A
DA
Delaney
C
C
Widdop
R E
RE
Carter
B E
BE
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D002211:Capsaicin / Q000627:therapeutic use*; D006562:Herpes Zoster / Q000150:complications*; D006358:Hot Temperature; D006801:Humans; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy / Q000209:etiology*; D012684:Sensory Thresholds / Q000187:drug effects*; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology*
D002211:Capsaicin